Safety & Risks: The Full Picture

Cardiac Risks — The Most Serious Concern

The most significant risk associated with ibogaine is QT interval prolongation — a change in the heart's electrical activity that can, in rare cases, lead to fatal cardiac arrhythmia (irregular heartbeat). In plain language: ibogaine can temporarily affect how your heart beats, and in people with pre-existing heart conditions or certain risk factors, this can be dangerous.

This is why proper medical screening and continuous cardiac monitoring are absolutely non-negotiable. Any clinic that does not perform a pre-treatment EKG and provide continuous cardiac monitoring during and after treatment should be avoided entirely.

Reported Fatalities

There are approximately 33 ibogaine-related deaths documented in the scientific literature to date. Context is important: the vast majority of these occurred in unregulated settings without medical monitoring, in individuals with pre-existing heart conditions that were not screened for, with concurrent drug use (particularly methadone or other QT-prolonging substances), or with impure or adulterated ibogaine products.

In properly screened patients treated at medically supervised facilities with continuous cardiac monitoring, the risk profile is significantly lower — though not zero. No medical treatment is without risk.

Other Side Effects

• Very common: Nausea and vomiting (most patients experience this)
• Common: Headache, ataxia (coordination difficulty), tremors, visual disturbances during the treatment
• Less common: Psychosis, mania (rare, usually in individuals predisposed to these conditions)
• Most side effects resolve within 24-72 hours after treatment

How Reputable Clinics Mitigate Risk

The safety protocols at a properly run ibogaine clinic include:

• Pre-treatment EKG/ECG screening
• Comprehensive blood panels and liver function testing
• Drug interaction screening
• Medication tapering protocols (SSRIs, methadone, etc.)
• Magnesium co-administration (Stanford protocol)
• Continuous cardiac monitoring during treatment and 24-72 hours post-treatment
• ACLS-certified medical staff on-site 24/7
• Psychiatric screening for contraindicated conditions

Who Should NOT Take Ibogaine

• People with certain heart conditions (long QT syndrome, arrhythmias, heart disease)
• People with liver disease
• Pregnant women
• People with untreated psychotic disorders (schizophrenia, bipolar disorder with psychotic features)
• People currently on certain medications (SSRIs must be tapered over 2-6 weeks, methadone requires careful specialist management, certain cardiac medications are contraindicated)

Red Flags: How to Identify a Dangerous Clinic

• No licensed medical doctor on-site
• No cardiac monitoring equipment
• No pre-treatment medical screening
• Extremely low prices (under $4,000 — they're cutting corners somewhere)
• High-pressure sales tactics
• Unwillingness to share staff credentials or answer detailed questions
• Vague or evasive about their medical protocols